Neuropathological diagnostic criteria for Alzheimer's disease.
about
APOE -ε4 allele for the diagnosis of Alzheimer's and other dementia disorders in people with mild cognitive impairment in a community settingAPOE -ε4 allele for the diagnosis of Alzheimer's and other dementia disorders in people with mild cognitive impairment in a secondary care settingAPOE -ε4 allele for the diagnosis of Alzheimer's and other dementia disorders in people with mild cognitive impairment in a primary care settingAntigen-antibody dissociation in Alzheimer disease: a novel approach to diagnosisHomeostatic capabilities of the choroid plexus epithelium in Alzheimer's diseaseNonhuman primate models of Alzheimer-like cerebral proteopathyConsortium to Establish a Registry for Alzheimer's Disease (CERAD): the first twenty years.Dissociated amyloid-beta antibody levels as a serum biomarker for the progression of Alzheimer's disease: a population-based study.Genes associated with the progression of neurofibrillary tangles in Alzheimer's disease.Current treatment and recent clinical research in Alzheimer's diseasePreliminary demonstration of an allelic association of the IREB2 gene with Alzheimer's diseaseSOD1 (copper/zinc superoxide dismutase) deficiency drives amyloid β protein oligomerization and memory loss in mouse model of Alzheimer diseaseIncidence and extent of TDP-43 accumulation in aging human brain.Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis.Monoclonal antibody against the turn of the 42-residue amyloid β-protein at positions 22 and 23Homovanillic acid and 5-hydroxyindole acetic acid as biomarkers for dementia with Lewy bodies and coincident Alzheimer's disease: An autopsy-confirmed study.Amyloid Plaques in Retina for Diagnosis in Alzheimer's Patients: a Meta-Analysis.Does Alzheimer's disease begin in the brainstem?Serum microRNA miR-501-3p as a potential biomarker related to the progression of Alzheimer's disease.An autopsy case of an aged patient with spinocerebellar ataxia type 2.Incidence and extent of Lewy body-related alpha-synucleinopathy in aging human olfactory bulb.The soluble transcobalamin receptor (sCD320) in relation to Alzheimer's disease and cognitive scores.Excess APP O-glycosylation by GalNAc-T6 decreases Aβ production.Protective effect of N-glycan bisecting GlcNAc residues on beta-amyloid production in Alzheimer's disease.Alzheimer's disease or Alzheimer's syndrome?: a longitudinal computed tomography neuroradiological follow-up study of 56 cases diagnosed clinically as Alzheimer's disease.Neuropathologic analysis of Lewy-related α-synucleinopathy in olfactory mucosa.Neuron-specific methylome analysis reveals epigenetic regulation and tau-related dysfunction of BRCA1 in Alzheimer's disease.Critical role of somatostatin receptor 2 in the vulnerability of the central noradrenergic system: new aspects on Alzheimer's disease.Lewy body pathology involves cutaneous nerves.Histopathologic Analysis of Cerebral Autosomal Recessive Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CARASIL): A Report of a New Genetically Confirmed Case and Comparison to 2 Previous Cases.Neuropathology of mild cognitive impairment.Everyday action in dementia: evidence for differential deficits in Alzheimer's disease versus subcortical vascular dementia.Cardiac sympathovagal modulation evaluated by short-term heart interval variability is subtly impaired in Alzheimer's disease.
P2860
Q24201260-17293EEE-EDFD-4287-8C0B-A8FFF2F810FFQ24201265-7F11333A-DF00-4D74-A7BE-9D4C6920E518Q24201271-1B3DB642-12C9-4280-B5BC-7B73287641DCQ24646892-7B2E6CFC-1BA9-4539-9334-39E43BA42C32Q24798001-870A979C-3462-42E4-BC23-1CBA014C4BAFQ28728135-D1BA7EAA-4FC0-42C8-8575-3EF7064AC2D8Q33600226-3A3EECDE-1943-4974-A76D-CD8C12A97BFDQ33625476-CCA63D0E-9F14-43E6-AE17-0EC2E6D4E0EEQ33840487-873873A6-E0CD-4E22-B510-F39AD8228A00Q34067487-4CF00BB2-D534-42A8-979E-078BE8C52523Q35009439-DF017D15-FEEA-41D0-A31D-50F04F98AAD2Q35639816-1B70D480-5C77-4860-9D57-C0BCEF14F1E5Q35759384-C3C10F7C-43C8-4C1E-9FA9-DFF85DF69F0CQ35800785-FA9FFD6D-9941-4192-9FA2-13294789AE29Q36012349-10A9A067-D5F4-423B-842B-135B9D5E6AAAQ36271739-53BBE2BF-7D07-4A4D-916E-FE0AB25749B0Q37405016-28EE1F07-CD28-4C88-B0C5-791F75D00FEEQ37456054-3480AF6E-1D15-4020-BC4B-234D0993AF94Q37615645-7D5D200B-1536-4130-9979-0ACB8318E7A2Q37816490-13DDA817-0E92-421A-A797-BABA0604D7DCQ38359613-EC41F01A-5512-4583-AC8D-C5C2422491F2Q38795972-36531E5E-08F3-4617-AA68-3726AC807980Q39039911-5563428F-1689-4C25-9211-3B5B902A8D34Q39796003-C20DC406-98D5-4CA1-89B7-3EEB52229220Q40107949-703F28B3-05A8-434A-9147-8B864C63C898Q46017333-F6580F51-F2A1-4BAA-8254-D9B28294A787Q47133918-D9E13F17-A495-4BAF-A49D-3312CD74C0E9Q48332119-06869F5E-C639-4B7F-91F6-A052030EAFC6Q48921589-FA8FE43B-BA52-4EDC-AF45-5C6839ED61A1Q51499978-D421328A-69CE-484A-9234-5AD47387AB41Q51727637-9725C83C-DB9E-4AB6-819C-83DA0112F921Q52027751-A54A4705-A0D3-42CD-89BB-E9D25414B061Q53296548-D78C8EDA-3C14-423B-9DCB-5DF89A70F5F6
P2860
Neuropathological diagnostic criteria for Alzheimer's disease.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Neuropathological diagnostic criteria for Alzheimer's disease.
@en
type
label
Neuropathological diagnostic criteria for Alzheimer's disease.
@en
prefLabel
Neuropathological diagnostic criteria for Alzheimer's disease.
@en
P2860
P1433
P1476
Neuropathological diagnostic criteria for Alzheimer's disease.
@en
P2093
Shigeo Murayama
Yuko Saito
P2860
P304
P356
10.1111/J.1440-1789.2004.00571.X
P577
2004-09-01T00:00:00Z